BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8182937)

  • 1. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
    Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z
    Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
    J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A
    J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of human macrophage inflammatory protein-1 alpha (LD78) on acute myeloid leukemia cells in vitro.
    Basara N; Stosić-Grujicić S; Sefer D; Ivanović Z; Antunović P; Milenković P
    Stem Cells; 1996 Jul; 14(4):445-51. PubMed ID: 8843546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D; Lemoine FM; Najman A; Guigon M
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitors.
    Estrov Z; Park CH; Reading CL; Estey EH; Talpaz M; Kurzrock R; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Aug; 20(7):886-90. PubMed ID: 1628706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S; Mantel C; Broxmeyer HE
    Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    Mantel C; Aronica S; Luo Z; Marshall MS; Kim YJ; Cooper S; Hague N; Broxmeyer HE
    J Immunol; 1995 Mar; 154(5):2342-50. PubMed ID: 7532666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
    Estrov Z; Talpaz M; Estey EH; Strassmann G
    Exp Hematol; 1995 Sep; 23(10):1080-7. PubMed ID: 7544738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
    Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
    Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
    de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
    Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine peritoneal macrophage colony-forming cells by peritoneal administration of macrophage inflammatory protein-1 alpha.
    Chen B; Chou TH; Sensenbrenner L
    Exp Hematol; 1993 Nov; 21(12):1591-6. PubMed ID: 8405240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.